PYMNTS.com June 30, 2022

What pandemic? With COVID-19 vaccinations and urgent care visits dropping through spring as infection fears faded, Big Pharmacy is looking to get back on track with expansion plans, a recovery in prescriptions and wellness sales products, and more access to primary care via the growing networks of retail primary care clinics being pursued by major chains.

Walgreens Boots Alliance (WBA) will remain an alliance on news that Walgreens ditched plans to sell the U.K.-based Boots chain of roughly 2,200 locations, citing market conditions and lack of an offer “that adequately reflects the high potential value of Boots,” the company said.

On its third-quarter 2022 earnings call with analysts on Thursday (June 30), WBA CEO Rosalind Brewer commented on depressed prescription...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Pharma, Pharma / Biotech, Primary care, Provider, Technology
Meet the 9 healthcare leaders on TIME's 'Most Influential People' list
Opinion: STAT+: How AI can help satisfy FDA’s drug, device diversity requirements
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
Pharmacies Should Adopt Proactive Health, Wellness to Help Patients

Share This Article